Search Within

Amrita V Herkal

Formats
  1. Meeting Abstract (6)
  2. Journal Article (1)
Groups
  1. Department of Medicine (7)
  2. Genitourinary Oncology Service (7)
  3. Solid Tumor Oncology Division (7)
  4. Biostatistics Service (3)
  5. Epidemiology and Biostatistics (3)
  6. Center for Molecular Imaging and Biotechnology (CMIB) (2)

More Groups

People
  1. Daniel Danila (7)
  2. Howard Scher (7)
  3. Martin Fleisher (7)
  4. Chintan Patel (6)
  5. Aseem Anand (5)
  6. Nicole Schreiber (5)

More People

Years
  1. 2016 (1)
  2. 2015 (2)
  3. 2013 (4)
Publications
  1. Journal of Clinical Oncology (4)
  2. Cancer Research (1)
  3. Journal of Molecular Diagnostics (1)
  4. The Cancer Journal (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (1)
  3. Elsevier Science, Inc. (1)
  4. Lippincott Williams & Wilkins (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical validity of detecting circulating tumor cells by AdnaTest assay compared with direct detection of tumor mRNA in stabilized whole blood, as a biomarker predicting overall survival for metastatic castration-resistant prostate cancer patients
    Journal Article

    Danila, D. C.; Samoila, A.; Patel, C.; Schreiber, N.; Herkal, A.; Anand, A.; Bastos, D.; Heller, G.; Fleisher, M.; Scher, H. I.
    The Cancer Journal (2016)

    Fulltext@MSK | Save
  • Predictive biomarkers of tumor sensitivity to STEAP1 antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Scher, H. I.; Szafer-Glusman, E.; Herkal, A.; Suttmann, R.; Fleisher, M.; Schreiber, N. A.; Curtis, K.; Gilbert, H.; Maslyar, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • STEAP1 as a predictive biomarker for antibody-drug conjugate (ADC) activity in metastatic castration resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Fleisher, M.; Carrasquillo, J. A.; Gilbert, H.; Morris, M. J.; Bellomo, L. P.; Hendrikx, P. J.; Szafer-Glusman, E.; Herkal, A.; Patel, C.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Danila, D. C.; Anand, A.; Heller, G.; Wan, M.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study comparing circulation tumor cells (CTC) detection by AdnaTest prostate assay to CellSearch in patients (pts) with castration resistant prostate cancer (CRPC)
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N. A.; Anand, A.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Prostate-specific mRNA detection in whole blood as an analytically validated prognostic biomarker for patients with castration-resistant prostate cancer (CRPC)
    Meeting Abstract

    Anand, A.; Danila, D. C.; Heller, G.; Herkal, A.; Patel, C.; Khanin, R.; Schultz, N.; Lilja, H.; Fleisher, M.; Scher, H. I.
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Validation of the aDNA test prostate assay sensitivity in detecting prostate-associated transcripts compared to the veridex cellsearch enumeration assay in patients with prostate sancer
    Meeting Abstract

    Samoila, A.; Bastos, D. A.; Anand, A.; Herkal, A.; Patel, C.; Curtis, K. R.; Schreiber, N.; Fleisher, M.; Scher, H. I.; Danila, D. C.
    Journal of Molecular Diagnostics (2013)

    Fulltext@MSK | Save